Oncotarget

Vol 11, No 32

August 11, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 32 of Oncotarget features Figure 2, "This figure depicts overall survival and local in-brain recurrence-free survival in the study’s subgroups," by Hussein, et al.

Table of Contents

Research Papers

Survival after resection of brain metastases with white light microscopy versus fluorescence-guidance: A matched cohort analysis of the Metastasys study data

Survival after resection of brain metastases with white light microscopy versus fluorescence-guidance: A matched cohort analysis of the Metastasys study data

https://doi.org/10.18632/oncotarget.27688

Abdelhalim Hussein, Veit Rohde, Christina Wolfert, Silvia Hernandez-Duran, Ingo Fiss, Annalen Bleckmann, Alonso Barrantes Freer, Dorothee Mielke,  and Bawarjan Schatlo
3026-3034
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL

Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL

https://doi.org/10.18632/oncotarget.27691

Yaya Chu, Aradhana Awasthi, Sanghoon Lee, Dina Edani, Changhong Yin, Jessica Hochberg, Tishi Shah, Tae-Hoon Chung, Janet Ayello, Carmella van de Ven, Christian Klein, Dean Lee,  and Mitchell S. Cairo
3035-3047
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models

Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models

https://doi.org/10.18632/oncotarget.27694

Leandro E. Mainetti, María José Rico, Cintia Daniela Kaufman, Monica Carolina Grillo, Julian Guercetti, María Virginia Baglioni, Antonela Del Giúdice, Maria Celeste Capitani, Matias Fusini, Viviana Rosa Rozados,  and O. Graciela Scharovsky
3048-3060
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients

Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients

https://doi.org/10.18632/oncotarget.27695

Aman Chauhan, Riham El-Khouli, Timothy Waits, Rohitashva Agrawal, Fariha Siddiqui, Zachary Tarter, Millicent Horn, Heidi Weiss, Elizabeth Oates, B. Mark Evers,  and Lowell Anthony
3061-3068
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells

Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells

https://doi.org/10.18632/oncotarget.27697

Rachael A. Clark, Sora Lee, Jingbo Qiao,  and Dai H. Chung
3069-3077
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Reviews

Important players in carcinogenesis as potential targets in cancer therapy: an update

Important players in carcinogenesis as potential targets in cancer therapy: an update

https://doi.org/10.18632/oncotarget.27689

Justyna Magdalena Hermanowicz, Iwona Kwiatkowska,  and Dariusz Pawlak
3078-3101
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Corrections

Correction: LRP6 promotes invasion and metastasis of colorectal cancer through cytoskeleton dynamics

Correction: LRP6 promotes invasion and metastasis of colorectal cancer through cytoskeleton dynamics

https://doi.org/10.18632/oncotarget.27710

Qian Yao, Yu An, Wei Hou, Ya-Nan Cao, Meng-Fei Yao, Ning-Ning Ma, Lin Hou, Hong Zhang, Hai-Jing Liu,  and Bo Zhang
3102-3102
Correction  |  PDF  |  How to cite

Correction: Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells

Correction: Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells

https://doi.org/10.18632/oncotarget.27597

Sham S. Kakar, Seema Parte, Kelsey Carter, Irving G. Joshua, Christopher Worth, Pranela Rameshwar,  and Mariusz Z. Ratajczak
3103-3104
Correction  |  PDF  |  How to cite


Copyright © 2020 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC